Blood Pressure

Systolic pressure (the upper number) measures the maximum force exerted on arterial walls when your heart contracts and pumps blood, typically ranging 90-140 mmHg in healthy adults. Diastolic pressure (the lower number) measures the minimum force when your heart relaxes between beats, normally 60-90 mmHg. Both numbers are critical because they reveal different aspects of cardiovascular health. For example, someone with 160/85 mmHg has isolated systolic hypertension (common in older adults due to arterial stiffening), indicating increased stroke risk even with normal diastolic. Conversely, 125/95 mmHg shows diastolic hypertension, often seen in younger adults, suggesting increased peripheral resistance and kidney stress. The difference between them—pulse pressure (calculated as systolic minus diastolic)—also matters: a value over 60 mmHg indicates arterial stiffness. Optimal blood pressure is less than 120/80 mmHg, where systolic below 120 AND diastolic below 80 both contribute to minimizing cardiovascular disease risk by approximately 50% compared to Stage 2 hypertension.

Blood pressure naturally increases with age due to arterial stiffening (arteriosclerosis), reduced vessel elasticity, and increased peripheral resistance—systolic pressure typically rises 0.5-1.0 mmHg per year after age 30. Age-specific targets reflect these physiological changes and risk-benefit analysis. For adults under 65, guidelines recommend treatment at 130/80 mmHg or higher, targeting below 130/80 mmHg to maximize cardiovascular protection. For adults 65+, targets are more lenient—treatment typically begins at 140/90 mmHg, targeting below 150/90 mmHg (or 140/90 if well-tolerated) because aggressive treatment increases fall risk, orthostatic hypotension, and kidney injury in elderly. For example, an 80-year-old with BP 145/85 mmHg might not require medication if otherwise healthy, whereas a 45-year-old with identical readings needs treatment. This reflects that a 70-year-old at 145/85 mmHg has similar cardiovascular risk to a 50-year-old at 135/85 mmHg. Pediatric blood pressure is even more nuanced, using percentile charts based on age, height, and gender—for a 10-year-old boy of average height, normal is below 110/75 mmHg, much lower than adult standards. Always consult healthcare providers for personalized age-appropriate targets, especially with diabetes, kidney disease, or cardiovascular history.

Validated home blood pressure monitors achieve accuracy within ±5 mmHg for 85-95% of readings when used correctly, comparable to clinical devices. However, improper technique causes errors of 10-20+ mmHg. Correct measurement protocol: (1) Avoid caffeine, exercise, and smoking for 30 minutes before measurement; (2) Sit quietly for 5 minutes in chair with back supported and feet flat on floor; (3) Position arm at heart level (mid-sternum)—arm below heart adds 10 mmHg, above subtracts 10 mmHg; (4) Use appropriately-sized cuff (bladder should encircle 80% of arm)—small cuff adds 5-15 mmHg, large cuff subtracts 3-10 mmHg; (5) Place cuff on bare arm 1 inch above elbow crease; (6) Don't talk during measurement; (7) Take 2-3 readings 1-2 minutes apart and average them; (8) Measure at consistent times (morning before medication, evening before dinner). Common errors: measuring over clothing (+5-10 mmHg), unsupported back (+5-10 mmHg), full bladder (+10-15 mmHg), crossed legs (+2-8 mmHg), talking during measurement (+10-15 mmHg). For validation, bring your home monitor to a doctor visit and compare simultaneous readings—difference should be under 5 mmHg. Home monitoring provides 20-30 readings versus the single clinical reading, offering superior diagnostic accuracy and detecting white coat hypertension (BP elevated only in medical settings, affecting 15-30% of patients) and masked hypertension (normal in clinic, elevated at home, affecting 10-15%).

Mean Arterial Pressure represents the average pressure in arteries during one cardiac cycle, calculated as: MAP = (Systolic + 2 × Diastolic) ÷ 3. This formula weighs diastolic more heavily because the heart spends approximately two-thirds of the cardiac cycle in diastole. For example, BP of 120/80 mmHg yields MAP = (120 + 160) ÷ 3 = 93 mmHg. MAP is clinically crucial because it represents the perfusion pressure driving blood to organs. Critical thresholds: MAP ≥ 60 mmHg is minimum required for adequate organ perfusion (brain, kidneys, heart); below this causes organ ischemia. MAP 70-100 mmHg is normal range providing optimal tissue oxygenation. MAP > 110 mmHg (e.g., BP 180/110) indicates hypertensive emergency risk. In critical care, MAP is the primary hemodynamic target—septic shock requires MAP ≥ 65 mmHg via fluids/vasopressors; traumatic brain injury targets MAP 80-90 mmHg for cerebral perfusion. MAP is also superior for assessing cardiovascular risk in certain populations: someone with 130/100 mmHg (MAP 110) has higher risk than 160/80 mmHg (MAP 107) despite lower systolic, because sustained elevated diastolic causes more kidney and heart damage. Additionally, MAP is less affected by measurement artifacts and body position than systolic or diastolic alone, making it more reliable for trending blood pressure changes over time or during exercise.

Essential (primary) hypertension comprises 90-95% of cases, with multifactorial causes: genetic predisposition (40-50% hereditary), obesity (each 10 kg weight gain increases BP 2-3 mmHg), high sodium intake (>2,300 mg daily raises BP 5-10 mmHg in salt-sensitive individuals), physical inactivity, excessive alcohol (>2 drinks/day), chronic stress, and aging. Treatment involves lifestyle modifications first: DASH diet reduces BP 8-14 mmHg; weight loss of 5-10 kg reduces BP 5-20 mmHg; sodium restriction to <1,500 mg daily reduces BP 5-6 mmHg; exercise 150 min/week reduces BP 5-8 mmHg. If lifestyle changes insufficient, medications follow the "ABCD" approach: ACE inhibitors/ARBs (reduce BP 10-15 mmHg, protect kidneys), Beta-blockers (reduce BP 10-12 mmHg, protect heart), Calcium channel blockers (reduce BP 8-10 mmHg, relax vessels), Diuretics (reduce BP 8-12 mmHg, reduce fluid volume). Secondary hypertension (5-10% of cases) has identifiable causes requiring specific treatment: Renal artery stenosis (narrowed kidney arteries, BP often >180/120, treated with angioplasty/stenting); Primary aldosteronism (adrenal tumor, BP 150-180/100-110 with low potassium, treated with spironolactone or surgery); Pheochromocytoma (adrenal tumor secreting catecholamines, causing episodic severe BP spikes 200-250/120-140, treated surgically); Cushing's syndrome (excess cortisol, treated by addressing underlying cause); Coarctation of aorta (congenital narrowing, higher BP in arms than legs, surgical repair). White coat hypertension (BP elevated only in medical settings) affects 15-30% of patients—typically managed with home monitoring and lifestyle modifications rather than medication unless cardiovascular risk is high. Correct diagnosis matters because treating secondary hypertension with antihypertensives alone is ineffective without addressing the underlying cause.

Blood pressure reduction must be carefully titrated because overly rapid decreases cause cerebral, cardiac, and renal hypoperfusion—the body adapts to chronic hypertension through cerebral autoregulation that maintains blood flow at higher pressures. Chronic hypertension (asymptomatic): Target gradual reduction over weeks to months. For Stage 1 hypertension (130-139/80-89 mmHg), reduce 5-10 mmHg over 3-6 months via lifestyle changes. For Stage 2 (≥140/90 mmHg), initiate medication targeting 10-20 mmHg reduction over 4-8 weeks, then continue to goal over 3-6 months. Faster reduction risks orthostatic hypotension (dizziness, falls, fractures, especially in elderly), coronary ischemia (reduced heart perfusion causing angina or infarction), and acute kidney injury (reduced renal perfusion, GFR drops). Hypertensive urgency (BP ≥180/120 without acute organ damage): Reduce by 25% over 24-48 hours, then to 160/100 over 2-6 hours using oral medications. Never normalize BP immediately—risk of stroke or blindness. Hypertensive emergency (BP ≥180/120 WITH acute organ damage—chest pain, stroke symptoms, pulmonary edema, renal failure): Requires hospitalization with IV medications targeting 10-20% reduction in first hour, then 5-15% reduction over next 23 hours. Excessive reduction below 140/90 mmHg in first 24 hours triples complication risk. Exception: Acute ischemic stroke requires permissive hypertension up to 220/120 mmHg for first 24-48 hours to maintain cerebral perfusion to ischemic areas—premature BP lowering extends infarct size. Elderly patients and those with long-standing hypertension especially need gradual titration over 3-6 months because their cerebral autoregulation curve has shifted rightward, making them symptomatic at pressures younger patients tolerate well.

Special populations require modified BP monitoring and targets due to differential risk profiles: Diabetes: Target is stricter <130/80 mmHg because hypertension accelerates diabetic complications—each 10 mmHg systolic increase doubles microvascular complication risk (retinopathy, nephropathy, neuropathy). Monitor BP at every diabetes visit (minimum quarterly). First-line treatment is ACE inhibitors or ARBs, which provide renal protection beyond BP lowering by reducing proteinuria 35-45%. Home monitoring is essential because diabetics have higher prevalence of masked hypertension (20-30%) and nocturnal hypertension (50-70%)—consider 24-hour ambulatory BP monitoring if home readings differ from clinic. Chronic Kidney Disease (CKD): Target <130/80 mmHg, more stringent if proteinuria present (<125/75 mmHg may benefit those with >1g protein/day). Monitor BP every 1-2 weeks when initiating/adjusting medications because CKD patients have impaired sodium excretion causing BP liability. ACE inhibitors/ARBs are preferred, but require careful monitoring—expect creatinine increase up to 30% (acceptable), but discontinue if >30% increase or potassium >5.5 mEq/L. CKD patients often need 3-4 antihypertensive medications for control due to volume overload and increased renin-angiotensin activity. Pregnancy: Normal pregnancy BP is <120/80 mmHg. Gestational hypertension (new onset ≥140/90 mmHg after 20 weeks) affects 6-8% of pregnancies. Preeclampsia (hypertension plus proteinuria/organ dysfunction after 20 weeks) affects 3-5%, requiring immediate treatment at ≥160/110 mmHg with IV labetalol or hydralazine to prevent maternal stroke while avoiding fetal hypoperfusion. Treatment threshold is ≥140/90 mmHg, target 120-160/80-105 mmHg (not normalized to avoid placental hypoperfusion). Monitor BP twice weekly if on medication, weekly if stable gestational hypertension. Postpartum BP typically normalizes by 12 weeks but requires 4-6 weeks monitoring. Chronic hypertension in pregnancy requires continuation of safe medications (labetalol, nifedipine, methyldopa) while avoiding ACE inhibitors/ARBs (teratogenic). Home BP monitoring in pregnancy detects preeclampsia earlier than clinic visits—threshold for concern is sustained readings ≥140/90 mmHg or increase of 30/15 mmHg from baseline.